期刊文献+

细支气管肺泡癌的流行现状 被引量:2

原文传递
导出
摘要 原发性支气管肺癌是全球发病率和病死率最高的恶性肿瘤,随着控烟运动的开展和普及,起始于大气道与吸烟相关的男性肺癌,特别是鳞癌的发病率和病死率已趋于稳定或缓慢下降。但是,随之而来的是女性肺癌,尤其是外周性腺癌的人数和比例呈明显上升,占肺癌的30%~70%。细支气管肺泡癌(bronchioloalveolar carcinoma,BAC)作为腺癌的一种重要亚型,其发病率也呈明显的上升趋势,尽管单纯性BAC发病率仅占肺癌发病率的4%左右,但伴有BAC成分的混合型BAC其发病率则可占肺癌的20%~30%。
作者 韩一平 李强
机构地区 长海医院呼吸科
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2009年第11期860-861,共2页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献12

  • 1Malassez L. Examen histologique d' un cas de cancer encephaloid du poumon (epithelioma). Archives de Physiologie Normale Pathologique, 1876,3 : 353 -372.
  • 2Liebow AA. Bronchiolo-alveolar carcinoma. Adv Inter Med, 1960, 10 : 329 -358.
  • 3Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloaveolar lung carcinoma and its unique clinicopatologic features. Cancer, 1994,73 : 1163-1170.
  • 4Auerbach O, Garfinkel L The changing pattern of lung carcinoma. Cancer, 1991,68:1973-1977.
  • 5Read WL, Page NC, Tierney RM, et al. The epidemiology of bronchioloalveolar carcinoma over the past two decades : analysis of the SEER database. Lung Cancer,2004,45:137-142.
  • 6贾心善,何安光,张道荣,王恩华,宋继谒.沈阳地区1224例肺癌20世纪80年代与90年代临床病理比较[J].中华病理学杂志,2001,30(5):332-335. 被引量:19
  • 7岳东升,王长利,张真发,战忠利.107例细支气管肺泡癌临床特征及预后分析[J].中国肿瘤临床,2007,34(9):515-518. 被引量:21
  • 8Travis WD, Colby TV, Corrin B, et al. Histological typing of lung and pleural tumours. 3rd ed. Berlin:Springer, 1999.
  • 9Falk RT, Pickle LW, Fontham ET, et al. Epidemiology of bronchioloalveolar carcinoma. Cancer Epidemiol Biomarkers Prev, 1992,1:339-344.
  • 10Zell JA, Ou SH, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol, 2005,23 : 8396-8405.

二级参考文献12

  • 1王敏,德永正羲,贾心善,丁俊义,侯正阶.胃癌与EB病毒关系的观察[J].中华病理学杂志,1994,23(5):285-287. 被引量:12
  • 2Jackman DM, Chrinieac LR, Janne PA. Bronchioloalveolar carcinoma: a review of the epidemiology, pathology,and treatment[J]. Semin Respir Crit Care Med, 2005, 26(3): 342~352.
  • 3Breathnach OS, Ishibe N, Williams J, et al. Clhfical features of patients with stage Ⅲ B and Ⅳ bronchioloalveolar carcinoma of the lung[J]. Cancer, 1999, 86(7): 1165~1173.
  • 4FurakJ, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occrrence,surgical treamaent and survival [J]. Eur J Cardiothorac Surg, 2003, 23(5): 818~823.
  • 5Rena O, Papalia E, Ruffini E. et ,al. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung [J]. Eur J Cardiothorac Surg, 2003, 23 (3) 409~414.
  • 6Breathnach OS, Kwiatkowski DJ, Finkelstein DM, et al. Bronchioloalveolar carcinoma of the lung: recurrences and survival in padents with stage Ⅰ disease [J]. J Thorac Cardiovasc Surg, 2001, 121(1): 42~47.
  • 7Barkley JE, Green MR. Bronchioloalveolar carcinoma [J]. J Clin Oncol, 1996, 14(8): 2377~2386.
  • 8Damhuis RA, Schutte PR, Varin OC, et al. Poor results after surgery for bronchioloalveolar carcinoma [J]. Eur J Surg Oncol, 2006, 32(5): 573~576.
  • 9Sakurai H, Dobashi Y, Mizutani E, et al. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter:a prognostic assessment[J]. Ann Thorac Surg, 2004, 78(5): 1728 ~1733.
  • 10Barlesi F, Doddoli C, Ginaenez C, et al. Bronchioloalveolar carcinoma:myths and realities in the surgical management [J]. Eur J Cardiothorac Surg, 2003, 24(1): 159~164.

共引文献37

同被引文献15

  • 1靳伟,蔡志钢.肺泡癌误诊为肺间质病变三例报告[J].临床误诊误治,2006,19(4):31-31. 被引量:3
  • 2Zell J A, Ou SH,Ziogas A, et al. Epidemiology of bronehioloalveolar carcinoma:improvement in survival after release of the 1999 WflO classification of lung tumnrs. J Clin Onco1,2005,23:8396-8405.
  • 3Aoki T,Nakata H,Watanaba H, et M. Evolution of peripheral lung adenocarcinomas:CT findings corerelated with histology and tumor doubling time. AJR Am J Rnentgenol,2000,174:763-768.
  • 4Inamura K, Ninomiya H, Ishikawa Y, et al. Is tile epidermal growth factor receptor status in lung cancers reflected in clinicopathologic teatures? Arch Pathol l,ah Med, 2010, 134 : 66- 72.
  • 5Ikeda K, Nomori H, Ohba Y, et al. Epidermal growth lactor receptor mutations in muhieentrie lung adenoearcinomas and atypical adenomalous hyperplasias. J Thorac Oneol, 2008,3 : 467- 471.
  • 6Linardou H, Dahabreh IJ, Bafaloukos D, et al. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC. Nat Rev Clin Oncol, 2009,6:352-366.
  • 7Lee HJ, Coo JM, Lee CH, et al. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radio1,2007 ,8 :22-31.
  • 8Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helica| computed tomography screening for lung cancer. J Comput Assisl Tomogr, 2004,28 : 17-23.
  • 9Barlesi F, Doddoli C, Gimenez C, et al. Bronehioloalveolar carcinoma: myths and realities in the surgical management. Eur J Cardiothorac Surg, 2003,24:159-164.
  • 10Scagliotti GV, Parikh P, yon P5wel J, et al. Phase Ⅲ study comparing cisplatin plus gemcitahine with cisplatin plus pemetrexed in chemotherapy-naive patients with arlvaneed-stage non-small-cell lung caneer. J Clin Oneol,2008,26: 3543-3551.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部